Alkermes (ALKS) Other Working Capital Changes (2010 - 2026)
Alkermes' (ALKS) quarterly Other Working Capital Changes came in at -$578000.0 in Q3 2025, up 40.53% year-on-year from -$411285.5 in Q3 2024, and up 43.88% on a QoQ basis from -$1.0 million in Q2 2025.
Alkermes (ALKS) Other Working Capital Changes (2010 - 2026) Analysis & Trends
Alkermes (ALKS) has 9 years of Other Working Capital Changes data on file, last reported at -$578000.0 in Q3 2025.
- On a quarterly basis, Other Working Capital Changes rose 40.53% year-over-year to -$578000.0 in Q3 2025; TTM through Dec 2025 was -$1.2 million, a 64.57% increase from a year earlier, with the FY2025 full-year figure at -$1.2 million, up 64.57% from the prior year.
- Other Working Capital Changes for Q3 2025 stood at -$578000.0, up from -$1.0 million in the prior quarter.
- Over the last five years, Other Working Capital Changes for ALKS reached as high as -$2.5 million in Q1 2024 and fell as low as -$19.8 million in Q4 2022.
- Historically, Other Working Capital Changes has averaged -$4.3 million across 5 years, with a median of -$2.8 million in 2026.
- Across the five-year window, Other Working Capital Changes slumped 439.6% in 2024 and soared 272.6% in 2025, its largest moves.
- Year by year, Other Working Capital Changes stood at -$1.4 million in 2021, then soared by 243.39% to $2.1 million in 2022, then tumbled by 109.8% to -$202000.0 in 2023, then slumped by 439.6% to -$1.1 million in 2024, then soared by 46.97% to -$578000.0 in 2025.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were -$578000.0 in Q3 2025, -$1.0 million in Q2 2025, and $359000.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Alkermes | 9.72 Bn | 9.21 Bn | 331.33 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.77 Mn |
| Mar 31, 2026 | -2.77 Mn |
| Mar 31, 2026 | -2.77 Mn |
| Dec 31, 2025 | -2.59 Mn |
| Dec 31, 2025 | -2.59 Mn |
| Dec 31, 2025 | -2.59 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Sep 30, 2025 | -2.60 Mn |
| Jun 30, 2025 | -2.59 Mn |
| Jun 30, 2025 | -2.59 Mn |
| Jun 30, 2025 | -2.59 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Mar 31, 2025 | -2.55 Mn |
| Dec 31, 2024 | -2.53 Mn |
| Dec 31, 2024 | -2.53 Mn |
| Dec 31, 2024 | -2.53 Mn |
| Sep 30, 2024 | -2.55 Mn |
| Sep 30, 2024 | -2.55 Mn |